logo
Impact Radar
  • Overview
  • Impact Performance
  • Compare this company
  • All sources
    • Sign UpLog In
    logo

    Alnylam Pharmaceuticals | Sustainability & Chart

    US02043Q1076

    Basic information on Alnylam Pharmaceuticals

    Location: United States

    Industry: Health Services

    Website

    knob-globe
    49%

    Impact Score

    Description Alnylam Pharmaceuticals

    Alnylam Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and commercializes RNA interference-based therapeutics to treat diseases with high unmet medical needs.

    Alnylam Pharmaceuticals Sustainability Performance

    Renewable Energy
    Greenhouse Gas Emissions
    Supply Chain
    Waste Recycling
    Sustainable [100]
    Almost sustainable [67-99]
    Moderate [34-66]
    Not sustainable [0-33]
    No data
    We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.

    Compare Alnylam Pharmaceuticals with ...

    Alnylam Pharmaceuticals

    ?

    Impact Score

    knob-globe
    49%
    knob-globe
    0%
    Climate
    Society
    Gender

    Sources of sustainability performance

    MetricValueUnitYearPDF NamePDF Page
    CEO Pay Ratio
    CEO nameYvonne L. Greenstreet2025alnylam-2025-annual-report.pdf160
    CEO-to-median-salary-ratio48Ratio20252026 ALNYLAM Proxy.pdf67
    Employee Turnover Rate
    Involuntary employee turnover8,42%2025alnylam-cr-report-2025.pdf97
    Voluntary employee turnover4,08%2025alnylam-cr-report-2025.pdf97
    Glass Ceiling
    Women in workforce56%2025alnylam-cr-report-2025.pdf44
    Women in management40%2025alnylam-cr-report-2025.pdf44
    Greenhouse Gas Emissions
    Scope 2 emissions, location based10 214Metric Tons of CO2e2025alnylam-cr-report-2025.pdf70
    Number of employees2 502people2025alnylam-cr-report-2025.pdf44
    Scope 1 emissions6 785Metric Tons of CO2e2025alnylam-cr-report-2025.pdf70
    Harassment and Discrimination at the Workplace
    Confidentiality mechanismsYes2025alnylam-cr-report-2025.pdf86
    Anti-discrimination policyYes2025code-of-business-conduct-and-ethics.pdf14
    Incident notification mechanismYes2025alnylam-cr-report-2025.pdf86
    Retaliation safeguardsYes2025alnylam-cr-report-2025.pdf86
    Supply Chain
    Scope 1 emissions6 785Metric Tons of CO2e2025alnylam-cr-report-2025.pdf70
    Scope 2 emissions, location based10 214Metric Tons of CO2e2025alnylam-cr-report-2025.pdf70
    Number of employees2 502people2025alnylam-cr-report-2025.pdf44
    Scope 3 emissions161 533Metric Tons of CO2e2025alnylam-cr-report-2025.pdf70
    Union Formation and Collective Bargaining Power
    Collective bargaining agreements coverage0%2025alnylam-2025-annual-report.pdf53
    Recycling and Recovery of Waste
    Waste recycled104,21Metric Tons2025alnylam-cr-report-2025.pdf75
    Total waste generation1 085,2Metric Tons2025alnylam-cr-report-2025.pdf75
    Women on Board
    Women on executive board1people20252026 ALNYLAM Proxy.pdf38
    Women on supervisory board40%2025alnylam-cr-report-2025.pdf82
    Executive board size6people20252026 ALNYLAM Proxy.pdf38
    Supervisory board size11people20252026 ALNYLAM Proxy.pdf10
    Women in Management
    Women in management40%2025alnylam-cr-report-2025.pdf44
    Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

    Find more sustainable companies

    logo
    HomeFind Companies & ETFsLearn to investAcademyGlossaryOur Method
    ImprintPrivacy PolicyGTCFAQContact Us
    © 2026 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The source of ETF data is the websites and data sheets of the respective ETF providers.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support!Logos provided by Logo.dev